MCG scientists hope non-invasive and better tests that measure a gene variant commonly found in bladder cancer could help improve patient outcomes.
In her new role, Dr. Martha S. Tingen will work to build a cancer prevention and control research program to assess the impact of healthier lifestyle choices on reducing preventable cancer deaths in the region.
A powerful immune molecule helps protect transplanted organs from rejection by putting a silencer on two other immune molecules that converge to take a direct shot at the organ, scientists report.
A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical needs they may have in the future.
Family, friends and faith. These are the things helping one father and grandfather live his life to the fullest after being diagnosed with cancer for the second time in under 10 years.
The story of ”Progeny” may be history, but the film’s message — the need for a world where cigars, cigarettes, and e-cigarettes are forgotten relics — is rooted firmly in the future.
According to the National Cancer Institute, more than 154,000 people will die from lung cancer in 2018, about the size of the population of Athens, Georgia.
An MCG lab has been designated to help with patient testing for a trial assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.
Dr. Martha Terris has a message for men, diagnosed with prostate cancer, who are not worried about follow-up visits with their oncologist.
Dr. Sharad Ghamande has been named executive vice chair of the MCG Department of Obstetrics and Gynecology.
January is Cervical Cancer Awareness Month and the Georgia Cancer Center has information about getting screened so you're not the next person to be diagnosed.
Cooperative group trial helping leukemia patients #url#
Dr. Carsten Schroeder turns the hybrid OR at AU Health into a one-stop shop for lung cancer patients.
Nearly 500 people living in the CSRA learned what changes they need to make to live a healthier lifestyle and lower their risk for developing the deadliest form of cancer.
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report. Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer...
The Georgia Cancer Center at Augusta University is one of 12 sites in the country to receive a National Cancer Institute grant to improve access to clinical trials for minorities and those living in rural communities. Dr. Sharad Ghamande and one of...
Directly injecting a tumor with an agent that activates a natural, powerful tumor suppressor enhances the drug’s capacity to attack the tumor both locally and where it spreads.
A protein that typically helps keep cells organized and on task becomes a tumor suppressor in the face of liver cancer, scientists say. The protein Scrib, which is emerging as both a tumor suppressor and oncogene depending on the cancer type...
In the war on cancer, powerful chemotherapy agents are increasingly packaged with immunotherapy that primes a patient’s immune system to better battle the disease. To strengthen their synergy, scientists are now focusing on immune cells that...
AUGUSTA, Ga. – Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report. Their studies of the protein Id1 also show high levels reduce conversion of unhealthy...